Export your current network:
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| A0A4W2BND6 | A0A4W2DK00 | A0A4W2BND6 | A0A4W2DK00 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.849 |
| A0A4W2BND6 | CTNNB1 | A0A4W2BND6 | A0A4W2BQK1 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Catenin beta 1. | 0.495 |
| A0A4W2BND6 | GRB10 | A0A4W2BND6 | A0A4W2HHG7 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor bound protein 10. | 0.654 |
| A0A4W2BND6 | IGF1 | A0A4W2BND6 | A0A4W2I474 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin like growth factor 1. | 0.913 |
| A0A4W2BND6 | IGF1R | A0A4W2BND6 | A0A4W2IC47 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.967 |
| A0A4W2BND6 | IGF2 | A0A4W2BND6 | A0A4W2GYD2 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin like growth factor 2. | 0.685 |
| A0A4W2BND6 | INSR | A0A4W2BND6 | A0A4W2IP97 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.982 |
| A0A4W2BND6 | IRS2 | A0A4W2BND6 | A0A4W2CV17 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2. | 0.895 |
| A0A4W2C5I5 | A0A4W2DK00 | A0A4W2C5I5 | A0A4W2DK00 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.849 |
| A0A4W2C5I5 | CTNNB1 | A0A4W2C5I5 | A0A4W2BQK1 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Catenin beta 1. | 0.495 |
| A0A4W2C5I5 | GRB10 | A0A4W2C5I5 | A0A4W2HHG7 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor bound protein 10. | 0.654 |
| A0A4W2C5I5 | IGF1 | A0A4W2C5I5 | A0A4W2I474 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin like growth factor 1. | 0.951 |
| A0A4W2C5I5 | IGF1R | A0A4W2C5I5 | A0A4W2IC47 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.967 |
| A0A4W2C5I5 | IGF2 | A0A4W2C5I5 | A0A4W2GYD2 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin like growth factor 2. | 0.685 |
| A0A4W2C5I5 | INSR | A0A4W2C5I5 | A0A4W2IP97 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.982 |
| A0A4W2C5I5 | IRS2 | A0A4W2C5I5 | A0A4W2CV17 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2. | 0.912 |
| A0A4W2DK00 | A0A4W2BND6 | A0A4W2DK00 | A0A4W2BND6 | Uncharacterized protein. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.849 |
| A0A4W2DK00 | A0A4W2C5I5 | A0A4W2DK00 | A0A4W2C5I5 | Uncharacterized protein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.849 |
| A0A4W2DK00 | GRB10 | A0A4W2DK00 | A0A4W2HHG7 | Uncharacterized protein. | Growth factor receptor bound protein 10. | 0.512 |
| A0A4W2DK00 | IGF1 | A0A4W2DK00 | A0A4W2I474 | Uncharacterized protein. | Insulin like growth factor 1. | 0.744 |
page 1 of 5